Ye et al.167 reported an activatable caspase-3 PA imaging probe (1-RGD)based on a biocompatible response-mediated self-assembly strategyby integration with a tumor-targeting ligand (i.e., c-RGD) and a PAimaging dye. Here, CASP3 is linked to neoplasm.